C12N 2750/00022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2750/00022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 20 US grants and 49 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 49
- Assignees
- 21
- Inventors
- 82
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 0 |
| 2015 | 1 | 3 |
| 2016 | 2 | 2 |
| 2017 | 4 | 2 |
| 2018 | 2 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 3 |
| 2021 | 1 | 0 |
| 2022 | 1 | 4 |
| 2023 | 0 | 7 |
| 2024 | 1 | 5 |
| 2025 | 0 | 6 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combination of vaccines to prophylactically treat a pig7 Apr 2026US 12,594,328 B2Intervet Inc.
- Surface-modified viral particles and modular viral particles3 Feb 2026US 12,540,337 B2Flagship Pioneering Innovations V, Inc.
- Mycovirus-induced gene silencing vector, construction method and application thereof5 Nov 2024US 12,134,773 B1Beijing Zhongbao Green Agricultural Science and Technology Group Co., Ltd
- Anellovirus compositions and methods of use20 Sep 2022US 11,446,344 B1Flagship Pioneering Innovations V, Inc.
- Anellovirus compositions and methods of use9 Nov 2021US 11,166,996 B2Flagship Pioneering Innovations V, Inc.
- Synthetic mrna comprising apoptin protein coding sequence and use thereof20 Aug 2026US 2026/0242423 A1Knu-Industry Cooperation Foundation
- Surface-modified viral particles and modular viral particles9 Apr 2026US 2026/0098280 A1Flagship Pioneering Innovations V, Inc.
- Anellosomes for delivering secreted therapeutic modalities8 Jan 2026US 2026/0009050 A1Flagship Pioneering Innovations V, Inc.
- Compositions comprising modified anellovirus capsid proteins and uses thereof16 Oct 2025US 2025/0320465 A1Flagship Pioneering Innovations V, Inc.
- In vitro assembly of anellovirus capsids enclosing rna14 Aug 2025US 2025/0257368 A1Flagship Pioneering Innovations V, Inc.
Most cited
By later US patents
- Anellovirus compositions and methods of use4US 11,446,344 B1Flagship Pioneering Innovations V, Inc. · 2022
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents4US 9,688,728 B2Proclara Biosciences, Inc. · 2017
- Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity3US 9,624,511 B2Deutsches Krebsforschungszentrum · 2017
- Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity3US 9,676,828 B2Deutsches Krebsforschungszentrum · 2017
- Vaccine formulations comprising saponin-containing adjuvants3US 9,730,987 B2Merial Limited · 2017